Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
John McCain completes first round of radiation and chemotherapy for brain tumor
Sat, 19 Aug 2017 08:49:02 GMT (New York Daily News)
Mom refuses brain tumor trial to save unborn baby
Tue, 15 Aug 2017 22:10:55 GMT (ABC News)
Brain tumor cells' adaptation to oxygen deprivation mapped ...
Wed, 16 Aug 2017 14:05:10 GMT (Science Daily)
Girl diagnosed with brain tumor after 'period pains' | Daily Mail Online
Thu, 17 Aug 2017 21:37:38 GMT (Daily Mail)
Senator: Brain tumor, late night may have influenced McCain's health vote
Wed, 09 Aug 2017 16:38:00 GMT (The Hill)
Mother with brain tumor: 'My life is beautiful, even if it stops today'
Fri, 11 Aug 2017 13:46:25 GMT (The Daily News Journal)
Genetic drivers of deadly brain cancer uncovered
Mon, 14 Aug 2017 16:16:19 GMT (Medical News Today)
New Drug Treats Same Type of Brain Cancer Sen. John McCain has
Tue, 25 Jul 2017 13:49:27 GMT (
3-D printer helps Missouri girl recover from brain tumor |
Mon, 14 Aug 2017 21:03:16 GMT (
Pregnant Michigan mom fights lethal brain tumor, hopes to give birth ...
Thu, 10 Aug 2017 13:48:20 GMT (
8/20/2017 2:54:56 PM
Feed cached:8/20/2017 4:02:34 PM

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.

Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls.
AJNR Am J Neuroradiol

Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.
AJNR Am J Neuroradiol

Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
Neuropathol Appl Neurobiol

Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.
AJNR Am J Neuroradiol

Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
J Magn Reson Imaging

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2017 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2017 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:8/20/2017 4:02:34 PM PST]